AMGN · 10-Q · 2026Q3 · Full report

Stock Repurchase Program

AMGEN INC · 2026-11-04 · Importance 10 · Surprise 6

Amgen repurchased no shares under its stock repurchase program during the nine months ended September 30, 2026, compared with no repurchases in the same 2025 period. As of September 30, 2026, $6.8 billion of authorization remained available under the program.

Key facts

• Amgen did not repurchase shares under its stock repurchase program during the nine months ended September 30, 2026; $6.8 billion of authorization remained available at that date. source
• As of September 30, 2026, $6.8 billion of authorization remained available under Amgen’s stock repurchase program. source
• Amgen did not repurchase shares under its stock repurchase program during the nine months ended September 30, 2026 or 2025. source